# A Phase I Study of Monoclonal Antibody TB-402 in Healthy Male Volunteers

> **NCT00612196** · PHASE1 · COMPLETED · sponsor: **ThromboGenics** · enrollment: 56 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** TB-402
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00612196
- **Lead sponsor:** ThromboGenics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2007-10
- **Final completion:** 2007-12
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2014-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00612196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00612196, "A Phase I Study of Monoclonal Antibody TB-402 in Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00612196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*